IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 59 filers reported holding IMMUNOCORE HLDGS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,942,304 | -13.4% | 576,923 | 0.0% | 35.70% | +29.7% |
| Q2 2023 | $34,592,303 | +21.3% | 576,923 | 0.0% | 27.53% | +9.3% |
| Q1 2023 | $28,523,073 | -13.4% | 576,923 | 0.0% | 25.19% | -0.7% |
| Q4 2022 | $32,924,996 | +21.5% | 576,923 | 0.0% | 25.37% | +18.4% |
| Q3 2022 | $27,100,000 | +26.0% | 576,923 | 0.0% | 21.42% | +29.6% |
| Q2 2022 | $21,500,000 | +25.0% | 576,923 | 0.0% | 16.53% | +78.7% |
| Q1 2022 | $17,200,000 | -69.2% | 576,923 | 0.0% | 9.25% | -45.4% |
| Q4 2021 | $55,800,000 | +160.7% | 576,923 | 0.0% | 16.93% | +170.2% |
| Q3 2021 | $21,400,000 | -7.0% | 576,923 | 0.0% | 6.26% | +77.3% |
| Q2 2021 | $23,000,000 | -6.4% | 576,923 | 0.0% | 3.53% | -12.1% |
| Q1 2021 | $24,560,000 | – | 576,923 | – | 4.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $21,500,000 | 16.53% |
| Velan Capital Investment Management LP | 293,385 | $10,946,000 | 11.10% |
| Paradigm Biocapital Advisors LP | 667,417 | $24,901,000 | 4.96% |
| RTW INVESTMENTS, LP | 3,996,154 | $149,097,000 | 3.85% |
| Rock Springs Capital Management LP | 2,671,652 | $99,679,000 | 2.90% |
| TANG CAPITAL MANAGEMENT LLC | 385,600 | $14,387,000 | 2.18% |
| Samsara BioCapital, LLC | 160,963 | $6,006,000 | 1.60% |
| Avidity Partners Management LP | 1,350,000 | $50,369,000 | 1.16% |
| Pier Capital, LLC | 123,394 | $4,604,000 | 0.78% |
| Omega Fund Management, LLC | 51,535 | $1,923,000 | 0.61% |